Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Sirona Biochem Corp.
  6. News
  7. Press Releases
    SBM   CA82967M1005

SIRONA BIOCHEM CORP.

(SBM)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société SIRONA BIOCHEM CORP.
09/22SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Discovery of Anti-Cellulite Activ..
AQ
09/22SIRONA BIOCHEM : Announces Discovery of Anti-Cellulite Activity in Compounds
AQ
06/30SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/
AQ
06/30SIRONA BIOCHEM : CEO Quarterly Update Q2 2021
AQ
03/31SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Reports Excellent Results in New Clinical S..
AQ
03/31SIRONA BIOCHEM : Reports Excellent Results in New Clinical Study on TFC-1067
AQ
03/10SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Launch of First Commercial Produc..
AQ
03/10SIRONA BIOCHEM : Announces Launch of First Commercial Product Containing TFC-1067
AQ
02/24SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Quarterly Update Q1 2021/
AQ
02/24SIRONA BIOCHEM : CEO Quarterly Update Q1 2021
AQ
02/03SIRONA BIOCHEM : Announces Grant of Stock Options
AQ
2020SIRONA BIOCHEM : Signs Agreement with Luxembourg-based CURE Intelligence for Social Media ..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Releases CEO Letter to Shareholders/
AQ
2020SIRONA BIOCHEM : Releases CEO Letter to Shareholders
AQ
2020SIRONA BIOCHEM : Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cos..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Acceptance of Clinical Study for ..
AQ
2020SIRONA BIOCHEM : Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cos..
AQ
2020SIRONA BIOCHEM : Signs Agreement with Global Pharmaceutical Company for Clinical Trial of ..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Signs Agreement with Global Pharmaceutical ..
AQ
2020SIRONA BIOCHEM : Signs Agreement with Global Pharmaceutical Company for Clinical Trial of ..
AQ
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Contracts WuXi AppTec for Large-Scale Manuf..
AQ
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fi..
AQ
2020SIRONA BIOCHEM : Ships First Batch of TFC-1067 to Rodan + Fields
AQ
2020SIRONA BIOCHEM : Interview with Chief Scientific Officer Dr. Deliencourt-Godefroy on the D..
AQ
2020/R E P E A T -- SIRONA BIOCHEM : Interview with Chief Scientific Officer Dr. Deliencourt-G..
AQ
2020SIRONA BIOCHEM : Interview with Chief Scientific Officer Dr. Deliencourt-Godefroy on the D..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Initiates COVID-19 and Infectious Diseases ..
AQ
2020SIRONA BIOCHEM : Initiates COVID-19 and Infectious Diseases Development Program
AQ
2020SIRONA BIOCHEM : Letter to the Shareholders
AQ
2020/R E P E A T -- SIRONA BIOCHEM : Letter to the Shareholders/
AQ
2020SIRONA BIOCHEM : Letter to the Shareholders
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Signs Letter of Intent with Top Chinese Pha..
AQ
2020SIRONA BIOCHEM : Signs Letter of Intent with Top Chinese Pharmaceutical Development Compan..
AQ
2020SIRONA BIOCHEM : Announces Change of Auditor
AQ
2020SIRONA BIOCHEM : 100% Safety in Final Tox Study for Increased Concentration of TFC-1067
AQ
2020/R E P E A T -- SIRONA BIOCHEM : 100% Safety in Final Tox Study for Increased Concentratio..
AQ
2020SIRONA BIOCHEM : 100% Safety in Final Tox Study for Increased Concentration of TFC-1067
AQ
2020SIRONA BIOCHEM : Announces Grant of Stock Options
AQ
2019SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Letter to Shareholders/
AQ
2019SIRONA BIOCHEM : CEO Letter to Shareholders
AQ
2019SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Reports 100% Safety in First Tox Study for ..
AQ
2019SIRONA BIOCHEM : Reports 100% Safety in First Tox Study for Increased Concentration of TFC..
AQ
2019SIRONA BIOCHEM : TFC-1067 Demonstrates Superiority to Hydroquinone for the Treatment of Dy..
PU
2019SIRONA BIOCHEM : to Exhibit at PCHi 2019 in Guanzhou China
PU
2019SIRONA BIOCHEM : Announces Financing
PU
2017SIRONA BIOCHEM : Announces Resignation of Board Director
PU
2017SIRONA BIOCHEM : Subsidiary, TFChem, Receives Final Loan Tranche from French Public Invest..
PU
2017SIRONA BIOCHEM : CEO's Report on Progress
PU
2016SIRONA BIOCHEM : CEO's Report on Progress
PU
2016SIRONA BIOCHEM : Initiates Research and Development on New Therapies for Keloid Scars and ..
PU
2016SIRONA BIOCHEM : Invited to Present at Dose of the Valley Conference, San Francisco
PU
2015SIRONA BIOCHEM : Grants Stock Options
PU
2015SIRONA BIOCHEM : Appoints German Private Bank Hauck & Aufhäuser as Designated Sponsor For ..
PU
2015SIRONA BIOCHEM : to Present at Industry's Premier Conference – BIO International Con..
PU
2015SIRONA BIOCHEM : to Present at BioNetwork East – May 2015
PU
Upcoming event on SIRONA BIOCHEM CORP.
10/05/21